Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plaque Psoriasis Vulgaris”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Early research (Phase 1)Study completedNCT01837576
What this trial is testing

An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Early research (Phase 1)Study completedNCT01466478
What this trial is testing

An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Not applicableStudy completedNCT03795402
What this trial is testing

Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling

Who this might be right for
Psoriasis Vulgaris
Janssen Research & Development, LLC 11
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Not applicableUnknownNCT05144165
What this trial is testing

Systemic Treatment of Moderate-to-severe Psoriasis in Adults: Update of the French Guidelines

Who this might be right for
PsoriasisPsoriasis PalmarisPsoriasis Inverse+8 more
Centre of Evidence of the French Society of Dermatology 30
Post-approval studies (Phase 4)Study completedNCT04183881
What this trial is testing

Clinical Study of Brodalumab

Who this might be right for
Psoriasis VulgarisPsoriatic ArthritisPustular; Psoriasis, Palmaris Et Plantaris+1 more
Kyowa Kirin Co., Ltd. 138
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)Study completedNCT05120297
What this trial is testing

Efficacy and Safety of AK101 in Subjects With Psoriasis

Who this might be right for
Psoriasis Vulgaris
Akeso 452
Testing effectiveness (Phase 2)Study completedNCT00593177
What this trial is testing

A Safety and Efficacy Study of a Topical Gel for the Treatment of Mild to Moderate Psoriasis

Who this might be right for
Psoriasis Vulgaris
Manhattan Pharmaceuticals 61
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Not applicableStudy completedNCT03828643
What this trial is testing

Secukinumab Efficacy Without the Initial Loading Dose in Patients With Psoriasis

Who this might be right for
Psoriasis Vulgaris
Universita di Verona 156
Early research (Phase 1)Study completedNCT01043224
What this trial is testing

A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Not applicableLooking for participantsNCT05243303
What this trial is testing

Augmenting Standard-of-care Treatment of Plaque Psoriasis by Neuromodulation

Who this might be right for
Psoriasis Vulgaris
Burrell College of Osteopathic Medicine 50
Not applicableStudy completedNCT06011083
What this trial is testing

Topical Calcipotriol /Betamethasone Ointment in the Treatment of Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisFractional CO2 Laser
Assiut University 40
Large-scale testing (Phase 3)Study completedNCT01636687
What this trial is testing

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

Who this might be right for
Plaque-type Psoriasis
Novartis Pharmaceuticals 182
Post-approval studies (Phase 4)Ended earlyNCT04533737
What this trial is testing

Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab

Who this might be right for
Plaque PsoriasisPsoriasis VulgarisPsoriasis
LEO Pharma 113
Testing effectiveness (Phase 2)Study completedNCT01347255
What this trial is testing

A Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis Vulgaris

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 24
Not applicableStudy completedNCT01707368
What this trial is testing

Non-interventional Study of Long-term Treatment of Psoriasis With Calcipotriol Plus Betamethasone in Gel Formulation

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
LEO Pharma 561
Not applicableNot Yet RecruitingNCT06414382
What this trial is testing

PSODEEP2 Pilot Study on Koebner Induction in Psoriasis

Who this might be right for
Psoriasis VulgarisKoebner Phenomenon
Skane University Hospital 15
Load More Results